Search by Drug Name or NDC

    NDC 11673-0433-12 headache relief 250; 250; 65 mg/1; mg/1; mg/1 Details

    headache relief 250; 250; 65 mg/1; mg/1; mg/1

    headache relief is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by Target Corporation. The primary component is ACETAMINOPHEN; ASPIRIN; CAFFEINE.

    Product Information

    NDC 11673-0433
    Product ID 11673-433_196901c0-9e01-4ee5-9482-68598faa87de
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name headache relief
    Proprietary Name Suffix n/a
    Non-Proprietary Name acetaminophen, aspirin, caffeine
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 250; 250; 65
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; ASPIRIN; CAFFEINE
    Labeler Name Target Corporation
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [E
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M013
    Listing Certified Through 2024-12-31

    Package

    NDC 11673-0433-12 (11673043312)

    NDC Package Code 11673-433-12
    Billing NDC 11673043312
    Package 1 BOTTLE, PLASTIC in 1 CARTON (11673-433-12) / 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
    Marketing Start Date 2019-04-01
    NDC Exclude Flag N
    Pricing Information N/A
    << 11673-0431-02 11673-0433-59 >>

    Contents